Introduction Cervical cancer is the leading cause of cancer deaths in women in the
developing world. New technologies have been developed to allow for more rapid, cost …

Each year in the United States, nearly 13,000 women develop cervical cancer and 4000 die
from the disease. 1 However, most cases can be prevented with vaccination and screening …

Background HPV testing is replacing cytology for cervical cancer screening because of
greater sensitivity and superior reassurance following negative tests for the dozen HPV …

Several lines of evidence suggested that antioxidants might play a protective role against
high-risk human papillomavirus (hrHPV) infection and cervical cancer. However, the effect of …

Human Papillomavirus (HPV) vaccination is a well-known fundamental strategy in the
prevention of cervical cancer, as it is always caused by HPV infection. In fact, primary …

Our aim was to review the major contributions of studies conducted in different Latin
American (LA) countries to the field of human papillomavirus (HPV) epidemiology, natural …

We conducted a critical appraisal of published Phase 2 and 3 efficacy trials in relation to the
prevention of cervical cancer in women. Our analysis shows the trials themselves generated …

Background Vaginal dysbiosis may paly role in increased risk of human papillomavirus
(HPV) infection. This study aims to explore potential vaginal microbiome biomarkers, to …

This study aims to evaluate the clinical performance of the HPV E6/E7 mRNA test in cervical
cancer screening in China. A hospital-based study was conducted with mRNA, DNA, and …

INTRODUCTION Human papillomavirus (HPV) is one of the major causes of head and neck
cancer (HNC). The incidence rate of newly diagnosed HPV-induced HNC cancer is on the …